| BUY | 35.200 | David Driscoll | Many of the health care stocks have started to recover or they are not down as much as the market this year. 4% yield and decent growth over time. | 2008-07-04 | |
| BUY | 42.090 | David Burrows | Had as a toe-hold in the pharmaceutical group that has been out of favour for 3 years, but with only medium success. Facing competition from the generics. Has a great portfolio of drugs and has pretty steady growth. | 2005-07-13 | |
| BUY | 44.340 | David Burrows | Pharmaceutical sector did very poorly over the last 2 years, but deceleration in revenue growth has slowed and profitability has started to improve. Look for the strongest perfoming stock in the sector. As Eli Lilly (LLY-N) is performing better, that would be the better of the 2, but would suggest you look at Sanofi-Aventis (SNY-N) which is close to new highs and Teva Pharmaceuticals (TEVA-Q) in generics. | 2005-05-03 | |
Experts that have talked about Sanofi-Aventis
Rss Top Picks Feed
